Get Premium to unlock powerful stock data

Novocure (NVCR) COO Wilhelmus Cm Groenhuysen Sold $3.7 million of Shares

Author's Avatar
insider
Sep 18, 2020
Article's Main Image

COO of Novocure (30-Year Financial, Insider Trades) Wilhelmus Cm Groenhuysen (insider trades) sold 34,512 shares of NVCR on 09/17/2020 at an average price of $107.81 a share. The total sale was $3.7 million.

NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors. NovoCure Ltd has a market cap of $11.19 billion; its shares were traded at around $110.74 with a P/E ratio of 922.84 and P/S ratio of 28.60.

CEO Recent Trades:

  • CEO Asaf Danziger sold 103,000 shares of NVCR stock on 09/15/2020 at the average price of $99. The price of the stock has increased by 11.86% since.

Directors and Officers Recent Trades:

  • COO Wilhelmus Cm Groenhuysen sold 34,512 shares of NVCR stock on 09/17/2020 at the average price of $107.81. The price of the stock has increased by 2.72% since.
  • Director Gabriel Leung sold 19,565 shares of NVCR stock on 09/15/2020 at the average price of $97.44. The price of the stock has increased by 13.65% since.
  • COO Wilhelmus Cm Groenhuysen sold 75,868 shares of NVCR stock on 09/15/2020 at the average price of $101.53. The price of the stock has increased by 9.07% since.
  • Director Gabriel Leung sold 19,114 shares of NVCR stock on 09/10/2020 at the average price of $87.8. The price of the stock has increased by 26.13% since.
  • Chief Commercial Officer Pritesh Shah sold 28,321 shares of NVCR stock on 09/09/2020 at the average price of $85.41. The price of the stock has increased by 29.66% since.

For the complete insider trading history of NVCR, click here

.
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus